As compared to conventional Vitamin K antagonists, anticoagulation with the novel factor Xa or thrombin inhibitors were found more effective in stroke prevention in patients with atrial fibrillation and more practical for handling.76,77 The safety and effectiveness of these new anticoagulants in patients with cervical artery dissection will need to be investigated in randomised trials. This evidence concerns the gene F10 and stroke disorder.